Naratriptan Size:Solid 10 mg Formula: C28H35N7O2

Formula: C28H35N7O2

decreasing anxiety

PI3K inhibitor GSK1059615 inhibits PI3K in the PI3K/AKT kinase signaling pathway

CID16020046 improves inflammation in models of intestinal inflammation and reduces proinflammatory cytokines

(2012) Cell Rep

Naratriptan Size:Solid 10 mg Formula: C28H35N7O2Naratriptan is a selective 5 HT1 receptor subtype agonist for the treatment of migraine headache. Naratriptan binds with high affinity to human cloned 5 HT1B 1D receptors. Migraines are likely due to local cranial vasodilatation and or to the release of sensory neuropeptides (including substance P and calcitonin gene related peptide) through nerve endings in the trigeminal system. The therapeutic activity of AMERGE for the treatment of migraine